Literature DB >> 1736612

Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter.

G Heinz1, P Siostrzonek, G Kreiner, H Gössinger.   

Abstract

Incessant supraventricular tachyarrhythmia may lead to a reversible impairment of left ventricular (LV) function. This issue was investigated in 10 patients (aged 64 +/- 13 years) who underwent radiofrequency His bundle ablation for control of drug refractory, chronic atrial fibrillation (n = 9) and recurrent atrial flutter (n = 1). LV function was assessed by 2-dimensional guided M-mode echocardiography within 24 hours (baseline) and 49 +/- 18 days (follow-up) after successful ablation, both during VVI pacing at 70 beats/min. Fractional shortening increased from 28 +/- 9% at baseline to 35 +/- 8% at follow-up (p = 0.006). This increase in fractional shortening was due to a significant reduction of end-systolic diameter from 41 +/- 10 to 36 +/- 10 mm (p = 0.02), whereas there was no appreciable change in end-diastolic diameter (56 +/- 7 to 55 +/- 10 mm; p = 0.5). These changes were substantially greater in patients with baseline impairment of LV function (fractional shortening less than 27%). Fractional shortening increased by 12% (p = 0.14) in patients with normal LV function (n = 5) and by 44% (p = 0.02) in those with impaired LV function at baseline (n = 5). The greater increase in fractional shortening in patients with preexisting LV impairment was due to a more pronounced decline in end-systolic dimensions (-11.9%; p = 0.08) compared with that of patients with normal LV function at baseline (-9.21%; p = 0.2). End-diastolic diameter showed no significant change in either group (-3.53% [p = 0.8] and -0.58% [p = 0.4]).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1736612     DOI: 10.1016/0002-9149(92)90991-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

Review 1.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

2.  Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter.

Authors:  Stephen Pizzale; Robert Lemery; Martin S Green; Michael H Gollob; Anthony S L Tang; David H Birnie
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

3.  Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias.

Authors:  A G Manolis; A G Katsivas; E E Lazaris; C V Vassilopoulos; N E Louvros
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

4.  Polymorphic ventricular tachycardia complicating radiofrequency catheter modification of the AV node for control of rapid ventricular response in atrial fibrillation.

Authors:  G K Feld
Journal:  J Interv Card Electrophysiol       Date:  1997-09       Impact factor: 1.900

5.  Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study.

Authors:  T Levy; S Walker; M Mason; P Spurrell; S Rex; S Brant; V Paul
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

6.  Hospitalization rate of paroxysmal supraventricular tachycardia in Sweden.

Authors:  Per Rosengren; Xinjun Li; Jan Sundquist; Kristina Sundquist; Bengt Zöller
Journal:  Ann Med       Date:  2018-10-15       Impact factor: 4.709

Review 7.  Ventricular arrhythmias in congestive heart failure: clinical significance and management.

Authors:  G R Khoshnevis; A Massumi
Journal:  Tex Heart Inst J       Date:  1999

8.  Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation.

Authors:  M Edner; K Caidahl; L Bergfeldt; B Darpö; N Edvardsson; M Rosenqvist
Journal:  Br Heart J       Date:  1995-09

Review 9.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 10.  Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia.

Authors:  Jonathan Weinstock; Paul J Wang; Munther K Homoud; Mark S Link; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.